Identification of plasma proteome signatures associated with ATN framework using SOMAscan Biomarkers (non-neuroimaging)/Use in clinical trial design and evaluation (2020)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/alz.036954
Publication URI: http://dx.doi.org/10.1002/alz.036954
Type: Journal Article/Review
Parent Publication: Alzheimer's & Dementia
Issue: S5